tetradecanoylphorbol acetate has been researched along with Gasser Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrionuevo, P; Camerano, G; Dran, G; Fernández, GC; Gómez, SA; Isturiz, MA; Palermo, MS; Rosa, FA | 1 |
Costello, C; Kim, J; Laurence, J; Mauro, M | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and Gasser Syndrome
Article | Year |
---|---|
Endogenous glucocorticoids modulate neutrophil function in a murine model of haemolytic uraemic syndrome.
Topics: Animals; Apoptosis; Cell Adhesion; Cell Migration Inhibition; Collagen Type II; Disease Models, Animal; Fibrinogen; Glucocorticoids; Hemolytic-Uremic Syndrome; Hormone Antagonists; Leukocyte Count; Male; Mice; Mice, Inbred BALB C; Mifepristone; Neutrophils; Phagocytosis; Reactive Oxygen Species; Receptors, Glucocorticoid; Serum Albumin, Bovine; Shiga Toxin 2; Tetradecanoylphorbol Acetate | 2005 |
Role of transforming growth factor beta1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome.
Topics: Apoptosis; Cell Cycle; Cell Lineage; Cells, Cultured; Coronary Vessels; Culture Media, Serum-Free; Endothelium, Vascular; Extracellular Matrix Proteins; Fibronectins; Hemolytic-Uremic Syndrome; HIV Infections; Humans; Liver; Organ Specificity; Palatine Tonsil; Platelet Aggregation Inhibitors; Platelet Count; Purpura, Thrombotic Thrombocytopenic; RNA, Messenger; Skin; Tetradecanoylphorbol Acetate; Thrombospondins; Ticlopidine; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2001 |